[1] | Zhou Q, Li L, Zhao B, Guan KL. The hippo pathway in heart development, regeneration, and diseases. Circ Res, 2015, 116(8): 1431-1447. | [2] | Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell, 2015, 163(4): 811-828. | [3] | McPherson JP, Tamblyn L, Elia A, Migon E, Shehabeldin A, Matysiak-Zablocki E, Lemmers B, Salmena L, Hakem A, Fish J, Kassam F, Squire J, Bruneau BG, Hande MP, Hakem R. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J, 2004, 23(18): 3677-3688. | [4] | Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science, 2011, 332(6028): 458-461. | [5] | Song H, Mak KK, Topol L, Yun KS, Hu J, Garrett L, Chen YB, Park O, Chang J, Simpson RM, Wang CY, Gao B, Jiang J, Yang YZ. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA, 2010, 107(4): 1431-1436. | [6] | Matsui Y, Nakano N, Shao D, Gao SM, Luo WT, Hong C, Zhai PY, Holle E, Yu XZ, Yabuta N, Tao WF, Wagner T, Nojima H, Sadoshima J. Lats2 is a negative regulator of myocyte size in the heart. Circ Res, 2008, 103(11): 1309-1318. | [7] | Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W, Milgram SL. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol, 2006, 26(1): 77-87. | [8] | Xin M, Kim Y, Sutherland LB, Murakami M, Qi XX, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, Richardson JA, Sadek HA, Bassel-Duby R, Olson EN. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA, 2013, 110(34): 13839-13844. | [9] | Xin M, Kim Y, Sutherland LB, Qi XX, McAnally J, Schwartz RJ, Richardson JA, Bassel-Duby R, Olson EN. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal, 2011, 4(196): ra70 | [10] | von Gise A, Lin ZQ, Schlegelmilch K, Honor LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD, Pu WT. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci USA, 2012, 109(7): 2394-2399. | [11] | Miesfeld JB, Link BA. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway. Mech Dev, 2014, 133: 177-188. | [12] | Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao JG, Yuan HX, Tumaneng K, Li HR, Fu XD, Mills GB, Guan KL. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell, 2012, 150(4): 78 |
[1] |
Yingchu Hu, Haochang Hu, Shaoyi Lin, Xiaomin Chen.
The role of DNA hydroxymethylation in the regulation of atherosclerosis
[J]. Hereditas(Beijing), 2020, 42(7): 632-640.
|
[2] |
Yuxi Li, Junhong Li, Dawang Zhou, .
Hippo signaling pathway in liver tissue homeostasis
[J]. Hereditas(Beijing), 2017, 39(7): 607-616.
|
[3] |
Lijuan Cao,Xinhe Liu,Qing Zha,Qian Song,Ke Yang,Yan Liu.
The relationship of SIRT3 with cellular metabolism and cardiovascular diseases
[J]. HEREDITAS(Beijing), 2015, 37(2): 111-120.
|
[4] |
Fei Xu, Jin Zhang, Duan Ma.
Crosstalk of Hippo/YAP and Wnt/β-catenin pathways
[J]. HEREDITAS, 2014, 36(2): 95-102.
|
[5] |
ZHEN Yi-Song, HUI Ru-Tai, XIONG Jing-Wei.
Recent progress in heart regeneration
[J]. HEREDITAS, 2011, 33(11): 1159-1163.
|
[6] |
LI Ya, ZHANG Si-Zhong, MA Yong-Xin, HE Yong, DONG Jing-Tao, SUN Yan, HE Guo-Ping, ZHANG Wei.
Relationship between the R219K Polymorphism of ATP-Binding Cassette Transporter 1 Gene and Coronary Heart Disease
[J]. HEREDITAS, 2005, 27(4): 549-552.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
|
|
|